Wastyk, 2021 - Google Patents
Determining Causal Relationships Between the Microbiome and Immune SystemWastyk, 2021
- Document ID
- 4943157985506186366
- Author
- Wastyk H
- Publication year
External Links
Snippet
The gut microbiome is a diverse ecosystem of~ 100 trillion microbes deeply embedded in multiple aspects of human immune and metabolic function. Defining the causal mechanisms underlying the gut-immune axis is imperative to understand dysregulation during disease …
- 230000001364 causal effect 0 title abstract description 21
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment; Prognosis
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wastyk et al. | Gut-microbiota-targeted diets modulate human immune status | |
Wan et al. | Underdevelopment of the gut microbiota and bacteria species as non-invasive markers of prediction in children with autism spectrum disorder | |
Gomez-Arango et al. | Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women | |
Yamada et al. | Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis | |
Davis et al. | Growth and morbidity of Gambian infants are influenced by maternal milk oligosaccharides and infant gut microbiota | |
Khor et al. | Interconnections between the oral and gut microbiomes: reversal of microbial dysbiosis and the balance between systemic health and disease | |
Shaffer et al. | Microbiome and metabolome data integration provides insight into health and disease | |
Bajaj et al. | Linkage of gut microbiome with cognition in hepatic encephalopathy | |
Shin et al. | Differential effects of typical Korean versus American-style diets on gut microbial composition and metabolic profile in healthy overweight Koreans: a randomized crossover trial | |
Mumolo et al. | Is gluten the only culprit for non-celiac gluten/wheat sensitivity? | |
Orlando et al. | Improved symptom profiles and minimal inflammation in IBS-D patients undergoing a long-term low-FODMAP diet: a lipidomic perspective | |
Acharya et al. | Salivary microbiome of an urban Indian cohort and patterns linked to subclinical inflammation | |
Lenhart et al. | Effect of exclusion diets on symptom severity and the gut microbiota in patients with irritable bowel syndrome | |
Sauer et al. | Nutriproteomics: Facts, concepts, and perspectives | |
Guard et al. | HORSE SPECIES SYMPOSIUM: Canine intestinal microbiology and metagenomics: From phylogeny to function | |
Wastyk et al. | Randomized controlled trial demonstrates response to a probiotic intervention for metabolic syndrome that may correspond to diet | |
Noh et al. | Taxonomic composition and diversity of the gut microbiota in relation to habitual dietary intake in Korean adults | |
Gaundal et al. | Gut microbiota is associated with dietary intake and metabolic markers in healthy individuals | |
Li et al. | The gut microbiome on a periodized low-protein diet is associated with improved metabolic health | |
Wang et al. | Meat consumption and gut microbiota: a scoping review of literature and systematic review of randomized controlled trials in adults | |
Mysonhimer et al. | Prebiotic consumption alters microbiota but not biological markers of stress and inflammation or mental health symptoms in healthy adults: A randomized, controlled, crossover trial | |
EP4120849A1 (en) | Microbiome fingerprints, dietary fingerprints, and microbiome ancestry, and methods of their use | |
Waldbaum et al. | Association between dysbiosis in the gut microbiota of primary osteoporosis patients and bone loss | |
Ramos-Nascimento et al. | Human gut microbiome and metabolite dynamics under simulated microgravity | |
Mendive Dubourdieu et al. | Understanding the link between gut microbiota, dietary intake, and nutritional status in children with autism and typical development |